Renaissance Technologies - AIM IMMUNOTECH INC ownership

AIM IMMUNOTECH INC's ticker is AIM and the CUSIP is 00901B105. A total of 40 filers reported holding AIM IMMUNOTECH INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of AIM IMMUNOTECH INC
ValueSharesWeighting
Q3 2023$88
-26.7%
192,308
+7.5%
0.00%
Q2 2023$120
+64.4%
178,808
+6.0%
0.00%
Q1 2023$73
+69.8%
168,708
+23.2%
0.00%
Q4 2022$43
-99.9%
136,908
+9.6%
0.00%
Q3 2022$73,000
-22.3%
124,908
+3.7%
0.00%
Q2 2022$94,000
-79.3%
120,408
-71.9%
0.00%
-100.0%
Q1 2022$454,000
-30.0%
428,071
-39.3%
0.00%0.0%
Q4 2021$649,000
+97.3%
705,100
+361.3%
0.00%
Q2 2021$329,000
-69.7%
152,848
-68.1%
0.00%
-100.0%
Q1 2021$1,087,000
+11977.8%
478,759
+2667.4%
0.00%
Q4 2019$9,00017,3000.00%
Other shareholders
AIM IMMUNOTECH INC shareholders Q2 2021
NameSharesValueWeighting ↓
XTX MARKETS LLC 11,019$20,0000.04%
Virtu Financial LLC 103,807$186,0000.02%
ACT WEALTH MANAGEMENT, LLC 10,000$18,0000.01%
SeaCrest Wealth Management, LLC 48,873$87,0000.01%
Arkadios Wealth Advisors 20,000$35,0000.01%
Traynor Capital Management, Inc. 14,777$26,0000.01%
GSA CAPITAL PARTNERS LLP 17,047$31,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 111,000$199,0000.00%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 20,200$36,0000.00%
Tower Research Capital LLC (TRC) 12,513$22,0000.00%
View complete list of AIM IMMUNOTECH INC shareholders